Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis

International Journal of Antimicrobial Agents

Volumn 33, Issue 3, 2009, Pages 223-229

  De Logu, Alessandro ^a   Palchykovska, Larisa H ^b   Kostina, Valentina H ^b   Sanna, Adriana ^a   Meleddu, Rita ^a   Chisu, Lorenza ^a   Alexeeva, Inna V ^b   Shved, Anatoly D ^b  

^a UNIVERSITY OF CAGLIARI   (Italy)

^b INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

Antimycobacterial agents; Mycobacterium tuberculosis; Phenazine derivatives

Indexed keywords

PHENAZINE DERIVATIVE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; DRUG SENSITIVITY; DRUG STRUCTURE; GROWTH INHIBITION; MACROPHAGE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; HUMANS; MACROPHAGES; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PHENAZINES;

EID: 60249094929     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2008.09.016     Document Type: Article

References (24)

1. World Health Organization. WHO report 2008. Global tuberculosis control - surveillance, planning, financing. Geneva, Switzerland: WHO. http://www.who.int/tb/publications/global_report/2008/summary/en/index.html [accessed 12 July 2008].
2. Morlock G.P., Plikaytis B.B., and Crawford J.T. Characterization of spontaneous, in vitro-selected, rifampin-resistant mutants of Mycobacterium tuberculosis strain H37Rv. Antimicrob Agents Chemother 44 (2000) 3298-3301
3. World Health Organization. Surveillance of drug resistance in tuberculosis. Geneva, Switzerland: WHO; 2007. http://www.who.int/tb/publications/dotsplus_surveillance/en/index.html [accessed 5 July 2008].
4. Dormandy J., Somoskovi A., Kreiswirth B.N., Driscoll J.R., Ashkin D., and Salfinger M. Discrepant results between pyrazinamide susceptibility testing by the reference BACTEC 460TB method and pncA DNA sequencing in patients infected with multidrug-resistant W-Beijing Mycobacterium tuberculosis strains. Chest 131 (2007) 497-501
5. Tanaka M., and Francis A.R. Detecting emerging strains of tuberculosis by using spoligotypes. Proc Natl Acad Sci USA 103 (2006) 15266-15271
6. Gurusiddaiah S., Weller D.M., Sarkar A., and Cook R.J. Characterization of an antibiotic produced by a strain of Pseudomonas fluorescens inhibitory to Gaeumannomyces graminis var. tritici and Pythium spp. Antimicrob Agents Chemother 29 (1986) 488-495
7. Herbert R.B., Holliman J.G., and Sheridan J.B. Synthesis of microbial phenazines: incorporation of shikimic acid. Tetrahedron Lett 8 (1976) 639-642
8. Turner J.M., and Messenger A.J. Occurrence, biochemistry and physiology of phenazine pigment production. Adv Microb Physiol 27 (1986) 211-275
9. Keudell K.C., Huang J.K., Wen L., Klopfenstein W.E., Bagby M.O., Lanser A.C., et al. Fatty acids enhanced tubermycin production by Pseudomonas strain 2HS. Microbios 102 (2000) 27-38
10. Franzblau S.G., White K.E., and O'Sullivan J.F. Structure-activity relationships of tetramethylpiperidine-substituted phenazines against Mycobacterium leprae in vitro. Antimicrob Agents Chemother 33 (1989) 2004-2005
11. Van Rensburg C.E., Joone G.K., Sirgel F.A., Matloa N.M., and O'Sullivan J.F. In vitro investigation of the antimicrobial activities of novel tetramethylpiperidine-substituted phenazines against Mycobacterium tuberculosis. Chemotherapy 46 (2000) 43-48
12. Palchykovska L.H., Platonov M.O., Alexeeva I.V., and Shved A.D. Composite bioregulators on the base of phenazine-1-carboxylic acid and 6-azauracil derivatives. Synthesis and structural characteristics. Biopolym Cell 19 (2003) 281-287
13. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89 (1986) 271-277
14. De Logu A., Onnis V., Saddi B., Congiu C., Schivo M.L., and Cocco M.T. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis. J Antimicrob Chemother 46 (2002) 275-282
15. Falzari K., Zhu Z., Pan D., Liu H., Hongmanee P., and Franzblau S.G. In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis. Antimicrob Agents Chemother 49 (2005) 1447-1454
16. Hassan H.M., and Fridovich F. Mechanism of antibiotic action of pyocyanine. J Bacteriol 141 (1980) 156-163
17. Hasset D.J., Schweizer H.P., and Ohman D.E. Pseudomonas aeruginosa sodA and sodB mutants defective in manganese- and iron-cofactored superoxide dismutase activity demonstrates the importance of the iron-cofactored formed in aerobic metabolism. J Bacteriol 177 (1995) 6330-6337
18. Kuo S.-C., Cano F.R., and Lampen J.O. Lomofungin, an inhibitor of ribonucleic acid synthesis in yeast protoplasts: its effect on enzyme formation. Antimicrob Agents Chemother 3 (1973) 716-722
19. Cano F.R., Kuo S.-C., and Lampen J.O. Lomofungin, an inhibitor of deoxyribonucleic acid-dependent ribonucleic acid polymerases. Antimicrob Agents Chemother 3 (1973) 723-728
20. Campbell E.A., Korzheva N., Mustaev A., Murakami K., Nair S., Goldfarb A., et al. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 104 (2001) 901-912
21. Fujii K., Saito H., Tomioka H., Mae T., and Hosoe K. Mechanism of action of antimycobacterial activity of the new benzoxazinorifamycin KRM-1648. Antimicrob Agents Chemother 39 (1995) 1489-1492
22. Reddy V.M., Nadadhur G., Daneluzzi D., O'Sullivan J.F., and Gangadharam P.R. Antituberculosis activity of clofazimine and its new analogs B4154 and B4157. Antimicrob Agents Chemother 40 (1996) 633-636
23. McAllister W.T. Transcription by T7 RNA polymerase. In: Eckstein F., and Lilley D.M.J. (Eds). Nucleic acids and molecular biology (1988), Springer, Berlin, Germany 1-14
24. Huitric E., Werngren J., Juréen P., and Hoffner S. Resistance levels and rpoB gene mutations among in vitro-selected rifampin-resistant Mycobacterium tuberculosis mutants. Antimicrob Agents Chemother 50 (2006) 2860-2862